543363 — PREVEST DENPRO Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual income statement for PREVEST DENPRO, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	228	376	499	564	630
Cost of Revenue
Gross Profit	158	278	372	425	504
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	182	236	309	379	428
Operating Profit	45.7	140	189	186	202
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	61.4	161	210	214	242
Provision for Income Taxes
Net Income After Taxes	51.2	116	157	161	182
Net Income Before Extraordinary Items
Net Income	51.2	116	157	161	182
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	51.2	116	157	161	182
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.26	9.64	13.1	13.4	15.1
Dividends per Share